XML 18 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 2 - Basis of Presentation
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
2.
Basis of Presentation
 
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and the instructions to Form
10
-Q and Article
10
of Regulation S-
X.
Accordingly, they do
not
include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the interim periods presented are
not
necessarily indicative of the results that
may
be expected for the year ending
December 31, 2018.
For further information, refer to the audited consolidated financial statements and notes included in the Company’s Annual Report on Form
10
-K for the year ended
December 31, 2017.
 
The preparation of the condensed consolidated financial statements in accordance with GAAP requires management of the Company to make a number of estimates and assumptions relating to the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates. The Company expects that the most significant estimates subject to change are the allowance for loan losses.
 
In the condensed consolidated statement of cash flows, the amounts for the
nine
months ended
September 30, 2017
have been corrected in the current year and differ from the previously reported amounts of
$159.1
million for net cash provided by investing activities,
$50.1
million for decrease in cash and cash equivalents,
$218.0
million for cash and cash equivalents, beginning of period and
$167.9
million for cash and cash equivalents, end of period.